Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
gptkb:public_company |
| gptkbp:focusesOn |
oncology
|
| gptkbp:foundedIn |
2010
|
| gptkbp:founder |
gptkb:John_V._Oyler
gptkb:Xiaodong_Wang |
| gptkbp:headquartersLocation |
gptkb:Beijing
gptkb:China |
| https://www.w3.org/2000/01/rdf-schema#label |
BeiGene
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:listedOn |
gptkb:NASDAQ
gptkb:Hong_Kong_Stock_Exchange gptkb:Shanghai_Stock_Exchange |
| gptkbp:notableProduct |
gptkb:Brukinsa
gptkb:tislelizumab |
| gptkbp:numberOfEmployees |
over 8,000
|
| gptkbp:operatesIn |
global
|
| gptkbp:stockExchange |
gptkb:NASDAQ
gptkb:Hong_Kong_Stock_Exchange |
| gptkbp:stockSymbol |
gptkb:BGNE
6160 688235 |
| gptkbp:type |
multinational
|
| gptkbp:website |
https://www.beigene.com/
|
| gptkbp:bfsParent |
gptkb:张磊
gptkb:Zhangjiang |
| gptkbp:bfsLayer |
6
|